Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Mixed start; African Barrick jumps

Thu, 16th Aug 2012 08:39

- African Barrick up as China Gold shows interest- Markets continue to sift through global economic data- Wen sees 'growing room for policy operation'London's benchmark index was broadly flat on Thursday morning as investors continue to digest a raft of economic data that has been released over the past few days.In the UK, minutes from the latest Monetary Policy Committee meeting showed that members voted unanimously this month in favour of maintaining the Bank of England Bank Rate at 0.5% and the asset purchase programme at £375bn. Unemployment in the UK fell from 8.1% to 8.0% in July, versus economists' expectations of no change. Market analyst Michael Hewson from CMC Markets said this morning that the figures "raise more questions than answers" with respect to the UK economy: "How can it be that unemployment is falling while the economy is in the grip of three successive quarters of economic contraction, and it is this apparent contradiction that is causing a lot of debate."Meanwhile, US data out yesterday afternoon came in mixed, with industrial output improving and New York manufacturing falling. Jobless claims and the Philly Fed index are due for release later today.Also in focus early on was the news of slowing inward investment in China in July. Foreign direct investment in China fell 8.7% to a two-year low of $7.58bn last month. Yesterday, Chinese Premier Wen Jiabao said that he sees "growing room for monetary policy operation" as inflation slows down.ABG jumps on takeover speculationAfrican Barrick Gold (ABG) jumped after announcing its holding company, Barrick Gold, is in talks with China National Gold Group about the possibility of selling its stake in the London-listed miner to China's largest gold producer. Should China Gold buy up more than 30% of the voting interest in ABG from Barrick Gold, it would then be required to make an offer for the whole of ABG's issued ordinary share capital. Pharmaceuticals group Hikma was a high riser after first-half revenues rose 34.8%, helped by contributions from recent acquisitions. Organic revenue growth was still a solid 7.6%.Software specialist Micro Focus edged higher after revealing news of a 50p-a-share cash return and share consolidation. The firm also said that first-quarter financials were in line with expectations, with adjusted earnings flat year-on-year on a constant currency basis. Engineering support services firm Babcock was in the red after Espirito Santo downgraded its rating on the stock to 'neutral', while natural gas giant BG Group fell after Morgan Stanley cut its rating to 'equal weight'.Publishing group Reed Elsevier was in demand after announcing the appointment of Duncan Palmer as its Chief Financial Officer, having lured him away from US company Owens Corning. Palmer will take over from Mark Armour, who is retiring at the end of the year. FTSE 100 - RisersWeir Group (WEIR) 1,747.00p +2.16%Polymetal International (POLY) 920.00p +1.55%Evraz (EVR) 266.20p +1.45%IMI (IMI) 896.50p +1.36%Vedanta Resources (VED) 931.00p +1.25%Kazakhmys (KAZ) 722.00p +0.98%Randgold Resources Ltd. (RRS) 6,180.00p +0.82%Capital Shopping Centres Group (CSCG) 332.80p +0.82%ITV (ITV) 85.85p +0.76%Tesco (TSCO) 335.10p +0.75%FTSE 100 - FallersAdmiral Group (ADM) 1,162.00p -1.69%Carnival (CCL) 2,158.00p -1.51%Eurasian Natural Resources Corp. (ENRC) 374.80p -1.26%BG Group (BG.) 1,305.50p -1.17%International Consolidated Airlines Group SA (CDI) (IAG) 146.00p -1.08%ICAP (IAP) 330.20p -0.90%Standard Life (SL.) 273.00p -0.84%ARM Holdings (ARM) 579.50p -0.77%Prudential (PRU) 817.00p -0.73%Vodafone Group (VOD) 187.40p -0.72%FTSE 250 - RisersAfrican Barrick Gold (ABG) 432.30p +9.83%Hikma Pharmaceuticals (HIK) 767.00p +5.79%Avocet Mining (AVM) 92.10p +4.24%Savills (SVS) 389.20p +2.99%NMC Health (NMC) 197.00p +2.18%New World Resources A Shares (NWR) 294.00p +2.05%Petra Diamonds Ltd.(DI) (PDL) 104.00p +1.96%Petropavlovsk (POG) 439.80p +1.62%Centamin (DI) (CEY) 70.50p +1.44%Jupiter Fund Management (JUP) 218.90p +1.39%FTSE 250 - FallersTalvivaara Mining Company (TALV) 134.10p -4.42%Balfour Beatty (BBY) 286.80p -3.14%CSR (CSR) 322.90p -3.00%Salamander Energy (SMDR) 208.00p -2.30%Bumi (BUMI) 354.10p -1.88%JD Sports Fashion (JD.) 664.92p -1.86%Galliford Try (GFRD) 626.50p -1.80%Wetherspoon (J.D.) (JDW) 465.10p -1.75%Redrow (RDW) 135.90p -1.74%Home Retail Group (HOME) 87.90p -1.62%BC
More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.